Date: October 30-31, 2019
Organised by: IQPC
With the past year seeing Kite Therapeutics and Novartis make headlines for their groundbreaking therapeutic approvals, and a host of innovative biotech companies quickly advancing their production towards commercialization, the Cell and Gene industry is rapidly transforming the standard of care for rare diseases and critical conditions.
While there is a huge opportunity for industry growth, ever-present challenges surrounding raw material selection and qualification, regulatory compliance, systems scalability and closed system processing prove barriers to achieving efficient commercial manufacturing scale.
Given the number of critical process challenges, the annual Cell and Gene Therapy Manufacturing Forum is the industries dedicated forum to address their process development, technical adoption, and manufacturing challenges.
So we’re very excited about our 1st participation in the conference.
If you are there, visit our booth and say hi to Frederik Jaenen & Pavel Verstraete.
And for sure… do not forget to put the presentation of Joachim Lasoen about Integrated CGT manufacturing Planning (30th of October 2019) on your agenda.
We hope to see you there!